$M?????? Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in KUBOTA PHARMACEUTICAL HOLDINGS CO LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in KUBOTA PHARMACEUTICAL HOLDINGS CO LTD. Get notifications about new insider transactions in KUBOTA PHARMACEUTICAL HOLDINGS CO LTD for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 66,587 | |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.50 | 1,250 | 8,125 | 11,108 | 12.4 K to 11.1 K (-10.11 %) |
Jul 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 12,358 | 9.7 K to 12.4 K (+27.47 %) |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 69,250 | |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.95 | 1,300 | 9,035 | 9,695 | 11 K to 9.7 K (-11.82 %) |
Jun 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 10,995 | 8.3 K to 11 K (+31.98 %) |
Jun 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 171,873 | |
Jun 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 7.38 | 3,380 | 24,944 | 40,354 | 43.7 K to 40.4 K (-7.73 %) |
Jun 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 43,734 | 36.3 K to 43.7 K (+20.61 %) |
Jun 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 7.38 | 1,080 | 7,970 | 70,134 | 71.2 K to 70.1 K (-1.52 %) |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 71,914 | |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.15 | 1,275 | 7,841 | 8,331 | 9.6 K to 8.3 K (-13.27 %) |
May 18 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 9,606 | 6.9 K to 9.6 K (+38.36 %) |
May 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 6.15 | 1,100 | 6,765 | 71,214 | 72.3 K to 71.2 K (-1.52 %) |
May 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 6.15 | 3,615 | 22,232 | 36,261 | 39.9 K to 36.3 K (-9.07 %) |
May 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 39,876 | 32.4 K to 39.9 K (+23.06 %) |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 74,577 | |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 6.48 | 1,320 | 8,554 | 6,943 | 8.3 K to 6.9 K (-15.97 %) |
Apr 17 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 8,263 | 5.6 K to 8.3 K (+47.58 %) |
Apr 04 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,472 | 0 | 186,819 | |
Apr 04 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 6.75 | 3,400 | 22,950 | 32,403 | 35.8 K to 32.4 K (-9.50 %) |
Apr 04 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,472 | 0 | 35,803 | 28.3 K to 35.8 K (+26.37 %) |
Apr 04 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 6.75 | 1,100 | 7,425 | 72,314 | 73.4 K to 72.3 K (-1.50 %) |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 77,241 | |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 7.10 | 1,250 | 8,875 | 5,599 | 6.8 K to 5.6 K (-18.25 %) |
Mar 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 6,849 | 4.2 K to 6.8 K (+63.62 %) |
Mar 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | J | 49,711,600.00 | 6,196,869 | 308,056,467,747,990 | 14,486,625 | 8.3 M to 14.5 M (+74.75 %) |
Mar 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Sell | J | 49,711,600.00 | 6,196,869 | 308,056,467,747,990 | 0 | 6.2 M to 0 (-100.00 %) |
Mar 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 7.72 | 1,250 | 9,650 | 73,414 | 74.7 K to 73.4 K (-1.67 %) |
Mar 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 194,291 | |
Mar 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 7.70 | 3,550 | 27,335 | 28,331 | 31.9 K to 28.3 K (-11.14 %) |
Mar 02 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 31,881 | 24.4 K to 31.9 K (+30.62 %) |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 79,904 | |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.10 | 1,450 | 11,745 | 4,186 | 5.6 K to 4.2 K (-25.73 %) |
Feb 21 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 5,636 | 3 K to 5.6 K (+89.64 %) |
Feb 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 150,643.00 | 17,200 | 2,591,063,212 | 8,289,756 | 8.3 M to 8.3 M (+0.21 %) |
Feb 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 111,884.00 | 12,900 | 1,443,307,857 | 8,272,556 | 8.3 M to 8.3 M (+0.16 %) |
Feb 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 869.60 | 100 | 86,960 | 8,259,656 | 8.3 M to 8.3 M (0.00 %) |
Feb 08 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 63,447.30 | 7,100 | 450,475,972 | 8,259,556 | 8.3 M to 8.3 M (+0.09 %) |
Feb 03 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 201,764 | |
Feb 03 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 8.60 | 3,875 | 33,325 | 24,408 | 28.3 K to 24.4 K (-13.70 %) |
Feb 03 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 28,283 | 20.8 K to 28.3 K (+35.91 %) |
Feb 03 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 8.50 | 1,250 | 10,625 | 74,664 | 75.9 K to 74.7 K (-1.65 %) |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 82,568 | |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.70 | 1,475 | 12,833 | 2,972 | 4.4 K to 3 K (-33.17 %) |
Jan 20 2017 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 4,447 | 1.8 K to 4.4 K (+149.27 %) |
Jan 10 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 22,970.10 | 2,700 | 62,019,135 | 8,252,456 | 8.2 M to 8.3 M (+0.03 %) |
Jan 10 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 143,507.00 | 16,900 | 2,425,270,497 | 8,249,756 | 8.2 M to 8.2 M (+0.21 %) |
Jan 10 2017 | M?????? | KUBOTA PHARMACEUTI ... | SBI Holdings, Inc. | 10% Owner | Buy | P | 1,735,240.00 | 204,800 | 355,376,994,304 | 8,232,856 | 8 M to 8.2 M (+2.55 %) |
Jan 06 2017 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 8.58 | 1,270 | 10,897 | 75,914 | 77.2 K to 75.9 K (-1.65 %) |
Jan 06 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 209,237 | |
Jan 06 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 8.58 | 3,790 | 32,518 | 20,810 | 24.6 K to 20.8 K (-15.41 %) |
Jan 06 2017 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 24,600 | 17.1 K to 24.6 K (+43.63 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,472 | 0 | 216,710 | |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 8.18 | 3,210 | 26,258 | 17,127 | 20.3 K to 17.1 K (-15.78 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,472 | 0 | 20,337 | 12.9 K to 20.3 K (+58.08 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 85,231 | |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 8.18 | 880 | 7,198 | 1,784 | 2.7 K to 1.8 K (-33.03 %) |
Dec 27 2016 | M?????? | KUBOTA PHARMACEUTI ... | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 2,664 | 0 to 2.7 K |
Dec 19 2016 | M?????? | KUBOTA PHARMACEUTI ... | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 8.75 | 1,090 | 9,538 | 77,184 | 78.3 K to 77.2 K (-1.39 %) |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 87,895 | |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.35 | 2,663 | 24,891 | 0 | 2.7 K to 0 (-100.00 %) |
Nov 21 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 2,663 | 0 to 2.7 K |
Nov 15 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.44 | 1,774 | 16,745 | 0 | 1.8 K to 0 (-100.00 %) |
Nov 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 224,182 | |
Nov 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 9.54 | 3,135 | 29,908 | 12,865 | 16 K to 12.9 K (-19.59 %) |
Nov 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 16,000 | 8.5 K to 16 K (+87.64 %) |
Nov 02 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 9.54 | 1,035 | 9,874 | 78,274 | 79.3 K to 78.3 K (-1.31 %) |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,664 | 0 | 90,558 | |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Payment of Exercise | F | 11.48 | 890 | 10,220 | 1,774 | 2.7 K to 1.8 K (-33.41 %) |
Oct 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,664 | 0 | 2,664 | 0 to 2.7 K |
Oct 04 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 231,655 | |
Oct 04 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 11.92 | 3,135 | 37,369 | 8,527 | 11.7 K to 8.5 K (-26.88 %) |
Oct 04 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 11,662 | 4.2 K to 11.7 K (+178.40 %) |
Oct 04 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 11.92 | 1,035 | 12,337 | 79,309 | 80.3 K to 79.3 K (-1.29 %) |
Sep 30 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 13.09 | 9,000 | 117,830 | 4,189 | 13.2 K to 4.2 K (-68.24 %) |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 2,663 | 0 | 93,222 | |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 9.53 | 2,663 | 25,382 | 0 | 2.7 K to 0 (-100.00 %) |
Sep 20 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 2,663 | 0 | 2,663 | 0 to 2.7 K |
Sep 12 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Sell | S | 9.86 | 60,000 | 591,420 | 13,189 | 73.2 K to 13.2 K (-81.98 %) |
Sep 02 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 9.84 | 1,035 | 10,184 | 80,344 | 81.4 K to 80.3 K (-1.27 %) |
Sep 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 239,128 | |
Sep 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 9.84 | 3,135 | 30,848 | 73,189 | 76.3 K to 73.2 K (-4.11 %) |
Sep 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 76,324 | 68.9 K to 76.3 K (+10.85 %) |
Sep 02 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 10.04 | 25,013 | 251,131 | 81,379 | 106.4 K to 81.4 K (-23.51 %) |
Aug 18 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Option Exercise | M | 5.48 | 75,101 | 411,553 | 165,222 | |
Aug 18 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Sell | S | 10.81 | 75,101 | 811,842 | 106,392 | 181.5 K to 106.4 K (-41.38 %) |
Aug 18 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Buy | M | 5.48 | 75,101 | 411,553 | 181,493 | 106.4 K to 181.5 K (+70.59 %) |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | M | 0.00 | 31,962 | 0 | 95,885 | |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Sell | S | 10.81 | 31,962 | 345,509 | 0 | 32 K to 0 (-100.00 %) |
Aug 18 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Buy | M | 0.00 | 31,962 | 0 | 31,962 | 0 to 32 K |
Aug 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,472 | 0 | 246,601 | |
Aug 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 12.70 | 3,135 | 39,815 | 68,851 | 72 K to 68.9 K (-4.36 %) |
Aug 02 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,472 | 0 | 71,986 | 64.5 K to 72 K (+11.58 %) |
Aug 02 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 12.70 | 1,035 | 13,145 | 106,392 | 107.4 K to 106.4 K (-0.96 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | J | 22.59 | 6,196,869 | 139,987,271 | 14,224,925 | 8 M to 14.2 M (+77.19 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | J | 22.59 | 4,160,115 | 93,976,998 | 6,196,869 | 2 M to 6.2 M (+204.25 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 22.15 | 617,800 | 13,684,270 | 8,028,056 | 7.4 M to 8 M (+8.34 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 17.67 | 478,600 | 8,456,862 | 7,410,256 | 6.9 M to 7.4 M (+6.90 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 19.05 | 991,000 | 18,878,550 | 6,931,656 | 5.9 M to 6.9 M (+16.68 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 16.21 | 456,400 | 7,398,244 | 5,940,656 | 5.5 M to 5.9 M (+8.32 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 16.13 | 555,000 | 8,952,150 | 5,484,256 | 4.9 M to 5.5 M (+11.26 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 16.03 | 723,200 | 11,592,896 | 4,929,256 | 4.2 M to 4.9 M (+17.19 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 12.53 | 776,300 | 9,727,039 | 4,206,056 | 3.4 M to 4.2 M (+22.63 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 11.13 | 257,000 | 2,860,410 | 3,429,756 | 3.2 M to 3.4 M (+8.10 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 9.30 | 1,018,400 | 9,471,120 | 3,172,756 | 2.2 M to 3.2 M (+47.27 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 9.63 | 256,300 | 2,468,169 | 2,154,356 | 1.9 M to 2.2 M (+13.50 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | P | 10.08 | 342,500 | 3,452,400 | 1,898,056 | 1.6 M to 1.9 M (+22.02 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | J | 5.72 | 69,628 | 398,272 | 1,555,556 | 1.5 M to 1.6 M (+4.69 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | J | 5.55 | 2,036,754 | 11,303,985 | 6,196,869 | 4.2 M to 6.2 M (+48.96 %) |
Jul 21 2016 | M?????? | ACUCELA INC. | SBI Holdings, Inc. | 10% Owner | Buy | J | 8.15 | 1,111,111 | 9,055,555 | 1,485,928 | 374.8 K to 1.5 M (+296.44 %) |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | A | 15.41 | 87,555 | 1,349,223 | 87,555 | |
Jul 14 2016 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Research & D ... | Option Exercise | A | 15.41 | 32,445 | 499,977 | 32,445 | |
Jul 14 2016 | M?????? | ACUCELA INC. | NAKAMURA EISAKU | Director | Option Exercise | A | 15.41 | 25,000 | 385,250 | 55,000 | |
Jul 14 2016 | M?????? | ACUCELA INC. | Asako Shintaro | Director | Option Exercise | A | 15.41 | 25,000 | 385,250 | 55,000 | |
Jul 14 2016 | M?????? | ACUCELA INC. | TAKEUCHI ROBERT | Director | Option Exercise | A | 15.41 | 25,000 | 385,250 | 55,000 | |
Jul 14 2016 | M?????? | ACUCELA INC. | MITA SHIRO | Director | Option Exercise | A | 15.41 | 25,000 | 385,250 | 55,000 | |
Jul 06 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 22.34 | 1,035 | 23,122 | 107,427 | 108.5 K to 107.4 K (-0.95 %) |
Jul 06 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 254,073 | |
Jul 06 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 22.34 | 3,135 | 70,036 | 64,514 | 67.6 K to 64.5 K (-4.63 %) |
Jul 06 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 67,649 | 60.2 K to 67.6 K (+12.42 %) |
Jun 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,473 | 0 | 261,546 | |
Jun 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 10.76 | 3,135 | 33,733 | 60,176 | 63.3 K to 60.2 K (-4.95 %) |
Jun 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 7,473 | 0 | 63,311 | 55.8 K to 63.3 K (+13.38 %) |
Jun 03 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 10.76 | 1,035 | 11,137 | 108,462 | 109.5 K to 108.5 K (-0.95 %) |
May 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | M | 0.00 | 89,673 | 0 | 269,019 | |
May 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Payment of Exercise | F | 35.90 | 33,835 | 1,214,677 | 55,838 | 89.7 K to 55.8 K (-37.73 %) |
May 03 2016 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Buy | M | 0.00 | 89,673 | 0 | 89,673 | 0 to 89.7 K |
May 03 2016 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Payment of Exercise | F | 35.90 | 8,872 | 318,505 | 109,497 | 118.4 K to 109.5 K (-7.50 %) |
Jan 25 2016 | M?????? | ACUCELA INC. | KUBOTA RYO | CEO, President and ... | Option Exercise | A | 10.14 | 32,538 | 329,935 | 32,538 | |
Jan 25 2016 | M?????? | ACUCELA INC. | KUBOTA RYO | CEO, President and ... | Option Exercise | A | 9.22 | 747,462 | 6,891,600 | 747,462 | |
Jan 25 2016 | M?????? | ACUCELA INC. | TAKEUCHI ROBERT | Director | Option Exercise | A | 9.22 | 30,000 | 276,600 | 30,000 | |
Jan 19 2016 | M?????? | ACUCELA INC. | Asako Shintaro | Director | Option Exercise | A | 9.06 | 30,000 | 271,800 | 30,000 | |
Jan 19 2016 | M?????? | ACUCELA INC. | NAKAMURA EISAKU | Director | Option Exercise | A | 9.06 | 30,000 | 271,800 | 30,000 | |
Jan 19 2016 | M?????? | ACUCELA INC. | MITA SHIRO | Director | Option Exercise | A | 9.06 | 30,000 | 271,800 | 30,000 | |
Dec 17 2015 | M?????? | ACUCELA INC. | KUBOTA RYO | CEO, President and ... | Option Exercise | M | 1.45 | 10,000 | 14,500 | 0 | |
Dec 17 2015 | M?????? | ACUCELA INC. | KUBOTA RYO | CEO, President and ... | Buy | M | 1.45 | 10,000 | 14,500 | 10,250,654 | 10.2 M to 10.3 M (+0.10 %) |
Sep 01 2015 | M?????? | ACUCELA INC. | Girard Roger | Chief Strategy Offi ... | Option Exercise | A | 0.00 | 365,276 | 0 | 365,276 | |
Aug 26 2015 | M?????? | ACUCELA INC. | LASEZKAY GEORGE M | EVP of Legal Affair ... | Option Exercise | A | 0.00 | 127,847 | 0 | 127,847 | |
Aug 19 2015 | M?????? | ACUCELA INC. | SCHEIBLER LUKAS | EVP of Translationa ... | Option Exercise | A | 0.00 | 127,847 | 0 | 127,847 | |
May 08 2015 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Option Exercise | A | 5.48 | 240,323 | 1,316,970 | 240,323 | |
May 05 2015 | M?????? | ACUCELA INC. | GEBHART JOHN E | Chief Financial Off ... | Option Exercise | A | 0.00 | 358,692 | 0 | 358,692 | |
May 05 2015 | M?????? | ACUCELA INC. | Tarr Steven C | Chief Operating Off ... | Grant | A | 0.00 | 358,692 | 0 | 358,692 | 0 to 358.7 K |
May 05 2015 | M?????? | ACUCELA INC. | DANSE EDWARD H | Chief Business Offi ... | Grant | A | 0.00 | 118,369 | 0 | 118,369 | 0 to 118.4 K |
Mar 26 2015 | M?????? | ACUCELA INC. | BLOCKER DEWEY H. JR. | VICE PRESIDENT FINA ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Mar 26 2015 | M?????? | ACUCELA INC. | BLOCKER DEWEY H. JR. | VICE PRESIDENT FINA ... | Option Exercise | A | 5.64 | 40,000 | 225,600 | 40,000 | |
Jan 29 2015 | M?????? | ACUCELA INC. | DEYOUNG HIEN | VP Human Resources | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 29 2015 | M?????? | ACUCELA INC. | DEYOUNG HIEN | VP Human Resources | Option Exercise | A | 5.78 | 20,000 | 115,600 | 20,000 | |
Jan 29 2015 | M?????? | ACUCELA INC. | O'CALLAGHAN BRIAN | Chief Executive Off ... | Option Exercise | A | 0.00 | 356,410 | 0 | 356,410 | |
Jan 29 2015 | M?????? | ACUCELA INC. | O'CALLAGHAN BRIAN | Chief Executive Off ... | Option Exercise | A | 5.78 | 712,480 | 4,118,134 | 712,480 |